Targeting Iron Homeostasis in Acute Kidney Injury

Seminars in Nephrology

Volumn 36, Issue 1, 2016, Pages 62-70

  Walker, Vyvyca J ^a   Agarwal, Anupam ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Ferritin; Ferroportin; Hepcidin; Injury; Iron; Kidney

Indexed keywords

DEFEROXAMINE; FERRITIN; FERROPORTIN; HEMOJUVELIN; HEPCIDIN; HEPHAESTIN; IRON; IRON CHELATING AGENT; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; REACTIVE OXYGEN METABOLITE; TRANSFERRIN;

ACUTE KIDNEY FAILURE; DNA DAMAGE; HOMEOSTASIS; HUMAN; IRON METABOLISM; IRON TRANSPORT; KIDNEY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ACUTE KIDNEY INJURY; BLOOD; METABOLISM; PHYSIOLOGY;

ACUTE KIDNEY INJURY; FERRITINS; HEPCIDINS; HOMEOSTASIS; HUMANS; IRON;

EID: 84960969050     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2016.01.003     Document Type: Review

References (100)

1. Rouault T.A. Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease. Dis Model Mech 2012, 5:155-164.
2. Kell D.B. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009, 2:2.
3. Gunshin H., Starr C.N., Direnzo C., Fleming M.D., Jin J., Greer E.L., et al. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood 2005, 106:2879-2883.
4. Mackenzie B., Garrick M.D. Iron imports. II. Iron uptake at the apical membrane in the intestine. Am J Physiol Gastrointest Liver Physiol 2005, 289:G981-G986.
5. Ma Y., Yeh M., Yeh K.Y., Glass J. Iron imports. V. Transport of iron through the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 2006, 290:G417-G422.
6. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., et al. A novel duodenal iron-regulated transporter, ireg1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000, 5:299-309.
7. Thomas C., Oates P.S. Ferroportin/ireg-1/mtp-1/slc40a1 modulates the uptake of iron at the apical membrane of enterocytes. Gut 2004, 53:44-49.
8. Chen H., Attieh Z.K., Su T., Syed B.A., Gao H., Alaeddine R.M., et al. Hephaestin is a ferroxidase that maintains partial activity in sex-linked anemia mice. Blood 2004, 103:3933-3939.
9. Muckenthaler M.U., Galy B., Hentze M.W. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (ire/irp) regulatory network. Annu Rev Nutr 2008, 28:197-213.
10. Le Blanc S., Garrick M.D., Arredondo M. Heme carrier protein 1 transports heme and is involved in heme-fe metabolism. Am J Physiol Cell Physiol 2012, 302:C1780-C1785.
11. Qiu A., Jansen M., Sakaris A., Min S.H., Chattopadhyay S., Tsai E., et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006, 127:917-928.
12. Ganz T., Nemeth E. Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta 2006, 1763:690-699.
13. Garrick M.D., Garrick L.M. Cellular iron transport. Biochim Biophys Acta 2009, 1790:309-325.
14. Dautry-Varsat A., Ciechanover A., Lodish H.F. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A 1983, 80:2258-2262.
15. Bali P.K., Aisen P. Receptor-modulated iron release from transferrin: differential effects on n- and c-terminal sites. Biochemistry 1991, 30:9947-9952.
16. Shindo M., Torimoto Y., Saito H., Motomura W., Ikuta K., Sato K., et al. Functional role of dmt1 in transferrin-independent iron uptake by human hepatocyte and hepatocellular carcinoma cell, hlf. Hepatol Res 2006, 35:152-162.
17. Liuzzi J.P., Aydemir F., Nam H., Knutson M.D., Cousins R.J. Zip14 (slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A 2006, 103:13612-13617.
18. Graham R.M., Chua A.C., Herbison C.E., Olynyk J.K., Trinder D. Liver iron transport. World J Gastroenterol 2007, 13:4725-4736.
19. Smith A., Hunt R.C. Hemopexin joins transferrin as representative members of a distinct class of receptor-mediated endocytic transport systems. Eur J Cell Biol 1990, 53:234-245.
20. Donovan A., Lima C.A., Pinkus J.L., Pinkus G.S., Zon L.I., Robine S., et al. The iron exporter ferroportin/slc40a1 is essential for iron homeostasis. Cell Metab 2005, 1:191-200.
21. De Domenico I., Lo E., Ward D.M., Kaplan J. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with jak2. Proc Natl Acad Sci U S A 2009, 106:3800-3805.
22. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
23. Smith C.P., Thevenod F. Iron transport and the kidney. Biochim Biophys Acta 2009, 1790:724-730.
24. Norden A.G., Lapsley M., Lee P.J., Pusey C.D., Scheinman S.J., Tam F.W., et al. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 2001, 60:1885-1892.
25. Li J.Y., Paragas N., Ned R.M., Qiu A., Viltard M., Leete T., et al. Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell 2009, 16:35-46.
26. Kozyraki R., Fyfe J., Verroust P.J., Jacobsen C., Dautry-Varsat A., Gburek J., et al. Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia. Proc Natl Acad Sci U S A 2001, 98:12491-12496.
27. Tchernitchko D., Bourgeois M., Martin M.E., Beaumont C. Expression of the two mRNA isoforms of the iron transporter Nramp2/DMTI in mice and function of the iron responsive element. Biochem J 2002, 363:449-455.
28. Wareing M., Ferguson C.J., Green R., Riccardi D., Smith C.P. In vivo characterization of renal iron transport in the anaesthetized rat. J Physiol 2000, 524:581-586.
29. Jorge-Nebert L.F., Galvez-Peralta M., Landero Figueroa J., Somarathna M., Hojyo S., Fukada T., et al. Comparing gene expression during cadmium uptake and distribution: untreated versus oral Cd-treated wild-type and ZIP14 knockout mice. Toxicol Sci 2015, 143:26-35.
30. Jenkitkasemwong S., Wang C.Y., Mackenzie B., Knutson M.D. Physiologic implications of metal-ion transport by ZIP14 and ZIP8. Biometals 2012, 25:643-655.
31. Khan A.A., Quigley J.G. Control of intracellular heme levels: heme transporters and heme oxygenases. Biochim Biophys Acta 2011, 1813:668-682.
32. Suzuki Y.A., Lonnerdal B. Baculovirus expression of mouse lactoferrin receptor and tissue distribution in the mouse. Biometals 2004, 17:301-309.
33. Nissenson A.R. Should medical directors assume responsibility for facility-specific outcomes?. Semin Dial 2012, 25:284-285.
34. Cheng X., Shen D., Samie M., Xu H. Mucolipins: intracellular trpml1-3 channels. FEBS Lett 2010, 584:2013-2021.
35. Gutierrez E., Egido J., Rubio-Navarro A., Buendia I., Blanco Colio L.M., Toldos O., et al. Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin Pract 2012, 121:c42-c53.
36. Ballarin J., Arce Y., Torra Balcells R., Diaz Encarnacion M., Manzarbeitia F., Ortiz A., et al. Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression. Nephrol Dial Transplant 2011, 26:3408-3411.
37. Tolosano E., Fagoonee S., Morello N., Vinchi F., Fiorito V. Heme scavenging and the other facets of hemopexin. Antioxid Redox Signal 2010, 12:305-320.
38. Moestrup S.K., Gliemann J., Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 1992, 269:375-382.
39. Zarjou A., Bolisetty S., Joseph R., Traylor A., Apostolov E.O., Arosio P., et al. Proximal tubule h-ferritin mediates iron trafficking in acute kidney injury. J Clin Invest 2013, 123:4423-4434.
40. Wolff N.A., Liu W., Fenton R.A., Lee W.K., Thevenod F., Smith C.P. Ferroportin 1 is expressed basolaterally in rat kidney proximal tubule cells and iron excess increases its membrane trafficking. J Cell Mol Med 2011, 15:209-219.
41. Yang Z., Philips J.D., Doty R.T., Giraudi P., Ostrow J.D., Tiribelli C., et al. Kinetics and specificity of feline leukemia virus subgroup c receptor (flvcr) export function and its dependence on hemopexin. J Biol Chem 2010, 285:28874-28882.
42. Chertow G.M., Burdick E., Honour M, Bonventre JV, Bates DW Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370.
43. Uchino S., Kellum J.A., Bellomo R., Doig G.S., Morimatsu H., Morgera S., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818.
44. American Society of Nephrology renal research report. J Am Soc Nephrol 2005, 16:1886-1903. American Society of Nephrology.
45. Baliga R., Ueda N., Shah S.V. Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J 1993, 291:901-905.
46. Rosner M.H., Okusa M.D. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006, 1:19-32.
47. Baliga R., Zhang Z., Baliga M., Shah S.V. Evidence for cytochrome p-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 1996, 49:362-369.
48. Baliga R., Zhang Z., Baliga M., Ueda N., Shah S.V. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998, 53:394-401.
49. Baliga R., Zhang Z., Baliga M., Ueda N., Shah S.V. Role of cytochrome p-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int 1998, 54:1562-1569.
50. Paller M.S., Jacob H.S. Cytochrome p-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci U S A 1994, 91:7002-7006.
51. Baron P., Gomez-Marin O., Casas C., Heil J., Will N., Condie R., et al. Renal preservation after warm ischemia using oxygen free radical scavengers to prevent reperfusion injury. J Surg Res 1991, 51:60-65.
52. Saad S.Y., Najjar T.A., Al-Rikabi A.C. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 2001, 43:211-218.
53. Bando Y., Aki K. Superoxide-mediated release of iron from ferritin by some flavoenzymes. Biochem Biophys Res Commun 1990, 168:389-395.
54. Biemond P., Swaak A.J., van Eijk H.G., Koster J.F. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radic Biol Med 1988, 4:185-198.
55. Bolann B.J., Ulvik R.J. Release of iron from ferritin by xanthine oxidase. Role of the superoxide radical. Biochem J 1987, 243:55-59.
56. Ueda N., Guidet B., Shah S.V. Gentamicin-induced mobilization of iron from renal cortical mitochondria. Am J Physiol 1993, 265:F435-F439.
57. Tangeras A., Flatmark T., Backstrom D., Ehrenberg A. Mitochondrial iron not bound in heme and iron-sulfur centers. Estimation, compartmentation and redox state. Biochim Biophys Acta 1980, 589:162-175.
58. Shah S.V. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989, 35:1093-1106.
59. Paller M.S., Hoidal J.R., Ferris T.F. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984, 74:1156-1164.
60. Paller M.S. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 1988, 255:F539-F544.
61. Kirschner R.E., Fantini G.A. Role of iron and oxygen-derived free radicals in ischemia-reperfusion injury. J Am Coll Surg 1994, 179:103-117.
62. Green C.J., Gower J.D., Healing G., Cotterill L.A., Fuller B.J., Simpkin S. The importance of iron, calcium and free radicals in reperfusion injury: an overview of studies in ischaemic rabbit kidneys. Free Radic Res Commun 1989, 7:255-264.
63. Shah S.V., Walker P.D. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol 1988, 255:F438-F443.
64. Walker P.D., Shah S.V. Hydrogen peroxide cytotoxicity in LLC-PK1 cells: a role for iron. Kidney Int 1991, 40:891-898.
65. Paller M.S., Hedlund B.E. Role of iron in postischemic renal injury in the rat. Kidney Int 1988, 34:474-480.
66. de Vries B., Walter S.J., von Bonsdorff L., Wolfs T.G., van Heurn L.W., Parkkinen J., et al. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation 2004, 77:669-675.
67. Ludwiczek S., Theurl I., Muckenthaler M.U., Jakab M., Mair S.M., Theurl M., et al. Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat Med 2007, 13:448-454.
68. Zager R.A., Johnson A.C., Becker K. Renal cortical hemopexin accumulation in response to acute kidney injury. Am J Physiol Renal Physiol 2012, 303:F1460-F1472.
69. Blachley J.D., Hill J.B. Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 1981, 95:628-632.
70. Jo S.K., Rosner M.H., Okusa M.D. Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol 2007, 2:356-365.
71. Schmidt-Ott K.M., Mori K., Kalandadze A., Li J.Y., Paragas N., Nicholas T., et al. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006, 15:442-449.
72. Schrier R.W., Wang W., Poole B., Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004, 114:5-14.
73. Star R.A. Treatment of acute renal failure. Kidney Int 1998, 54:1817-1831.
74. Moriguchi J., Ezaki T., Tsukahara T., Furuki K., Fukui Y., Okamoto S., et al. Comparative evaluation of four urinary tubular dysfunction markers, with special references to the effects of aging and correction for creatinine concentration. Toxicol Lett 2003, 143:279-290.
75. Sato R., Suzuki Y., Takahashi G., Kojika M., Inoue Y., Endo S. A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care. J Infect Chemother 2015, 21:165-169.
76. Kashani K., Al-Khafaji A., Ardiles T., Artigas A., Bagshaw S.M., Bell M., et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013, 17:R25.
77. Koyner J.L., Vaidya V.S., Bennett M.R., Ma Q., Worcester E, Akhter SA, et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010, 5:2154-2165.
78. Scindia Y., Dey P., Thirunagari A., Liping H., Rosin D.L., Floris M., et al. Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis. J Am Soc Nephrol 2015, 26:2800-2814.
79. Young G.H., Huang T.M., Wu C.H., Lai C.F., Hou C.C., Peng K.Y., et al. Hemojuvelin modulates iron stress during acute kidney injury: improved by furin inhibitor. Antioxid Redox Signal 2014, 20:1181-1194.
80. Niederkofler V., Salie R., Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005, 115:2180-2186.
81. Rodriguez Martinez A., Niemela O., Parkkila S. Hepatic and extrahepatic expression of the new iron regulatory protein hemojuvelin. Haematologica 2004, 89:1441-1445.
82. Haase-Fielitz A., Mertens P.R., Plass M., Kuppe H., Hetzer R., Westerman M., et al. Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: an observational cohort study. Crit Care 2011, 15:R186.
83. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001, 276:7811-7819.
84. Bolisetty S., Zarjou A., Hull T.D., Traylor A.M., Perianayagam A., Joseph R., et al. Macrophage and epithelial cell h-ferritin expression regulates renal inflammation. Kidney Int 2015, 88:95-108.
85. Mishra J., Dent C., Tarabishi R., Mitsnefes M.M., Ma Q., Kelly C., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
86. Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003, 14:2534-2543.
87. Berger T., Togawa A., Duncan G.S., Elia A.J., You-Ten A., Wakeham A., et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A 2006, 103:1834-1839.
88. Ferenbach D.A., Kluth D.C., Hughes J. Hemeoxygenase-1 and renal ischaemia-reperfusion injury. Nephron Exp Nephrol 2010, 115:e33-e37.
89. Hull T.D., Kamal A.I., Boddu R., Bolisetty S., Guo L., Tisher C.C., et al. Heme oxygenase-1 regulates myeloid cell trafficking in AKI. J Am Soc Nephrol 2015, 26:2139-2151.
90. Nath K.A. Heme oxygenase-1 and acute kidney injury. Curr Opin Nephrol Hypertens 2014, 23:17-24.
91. Morimoto K., Ohta K., Yachie A., Yang Y., Shimizu M., Goto C., et al. Cytoprotective role of heme oxygenase (ho)-1 in human kidney with various renal diseases. Kidney Int 2001, 60:1858-1866.
92. Zager R.A., Johnson A.C., Becker K. Plasma and urinary heme oxygenase-1 in AKI. J Am Soc Nephrol 2012, 23:1048-1057.
93. Askenazi D.J., Halloran B., Patil N., Keeling S., Saeidi B., Koralkar R., et al. Genetic polymorphisms of heme-oxygenase 1 (ho-1) may impact on acute kidney injury, bronchopulmonary dysplasia and mortality in premature infants. Pediatr Res 2015, 77:793-798.
94. Baan C., Peeters A., Lemos F., Uitterlinden A., Doxiadis I., Claas F., et al. Fundamental role for HO-1 in the self-protection of renal allografts. Am J Transplant 2004, 4:811-818.
95. Katavetin P., Inagi R., Miyata T., Shao J., Sassa R., Adler S., et al. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 2007, 359:928-934.
96. Lam C.W., Getting S.J., Perretti M. In vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation. J Immunol 2005, 174:2297-2304.
97. Lee T.S., Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002, 8:240-246.
98. Mori K., Lee H.T., Rapoport D., Drexler I.R., Foster K., Yang J., et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005, 115:610-621.
99. Zou L., Sato N., Attuwaybi B.O., Kone B.C. Delayed administration of alpha-melanocyte-stimulating hormone or combined therapy with bay 11-7085 protects against gut ischemia-reperfusion injury. Shock 2003, 20:469-475.
100. Zarjou A., Balla J., Balla G., Agarwal A. Iron metabolism and oxidative stress. Studies on renal disorders 2011, Humana Press, New York. T. Miyata, K. Eckardt, M. Nanhaku (Eds.).